• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RESIGN:基于混合深度学习的Res-Inception分割网络用于阿尔茨海默病检测

RESIGN: Alzheimer's Disease Detection Using Hybrid Deep Learning based Res-Inception Seg Network.

作者信息

Amsavalli K, Suba Raja S Kanaga, Sudha S

机构信息

Department of Artificial Intelligence and Data Science, Easwari Engineering College, Chennai, India.

Department of Computer Science and Engineering, SRM Institute of Science and Technology, Tiruchirappalli, Tamil Nadu, India.

出版信息

Curr Alzheimer Res. 2025 Jun 18. doi: 10.2174/0115672050373821250612053943.

DOI:10.2174/0115672050373821250612053943
PMID:40539353
Abstract

INTRODUCTION

Alzheimer's disease (AD) is a leading cause of death, making early detection critical to improve survival rates. Conventional manual techniques struggle with early diagnosis due to the brain's complex structure, necessitating the use of dependable deep learning (DL) methods. This research proposes a novel RESIGN model is a combination of Res-InceptionSeg for detecting AD utilizing MRI images.

METHODS

The input MRI images were pre-processed using a Non-Local Means (NLM) filter to reduce noise artifacts. A ResNet-LSTM model was used for feature extraction, targeting White Matter (WM), Grey Matter (GM), and Cerebrospinal Fluid (CSF). The extracted features were concatenated and classified into Normal, MCI, and AD categories using an Inception V3-based classifier. Additionally, SegNet was employed for abnormal brain region segmentation.

RESULTS

The RESIGN model achieved an accuracy of 99.46%, specificity of 98.68%, precision of 95.63%, recall of 97.10%, and an F1 score of 95.42%. It outperformed ResNet, AlexNet, Dense- Net, and LSTM by 7.87%, 5.65%, 3.92%, and 1.53%, respectively, and further improved accuracy by 25.69%, 5.29%, 2.03%, and 1.71% over ResNet18, CLSTM, VGG19, and CNN, respectively.

DISCUSSION

The integration of spatial-temporal feature extraction, hybrid classification, and deep segmentation makes RESIGN highly reliable in detecting AD. A 5-fold cross-validation proved its robustness, and its performance exceeded that of existing models on the ADNI dataset. However, there are potential limitations related to dataset bias and limited generalizability due to uniform imaging conditions.

CONCLUSION

The proposed RESIGN model demonstrates significant improvement in early AD detection through robust feature extraction and classification by offering a reliable tool for clinical diagnosis.

摘要

引言

阿尔茨海默病(AD)是主要的死亡原因之一,因此早期检测对于提高生存率至关重要。由于大脑结构复杂,传统的手工技术在早期诊断方面存在困难,这就需要使用可靠的深度学习(DL)方法。本研究提出了一种新颖的RESIGN模型,它是Res-InceptionSeg的组合,用于利用MRI图像检测AD。

方法

使用非局部均值(NLM)滤波器对输入的MRI图像进行预处理,以减少噪声伪影。使用ResNet-LSTM模型进行特征提取,目标是白质(WM)、灰质(GM)和脑脊液(CSF)。提取的特征进行拼接,并使用基于Inception V3的分类器分为正常、轻度认知障碍(MCI)和AD类别。此外,使用SegNet进行异常脑区分割。

结果

RESIGN模型的准确率达到99.46%,特异性为98.68%,精确率为95.63%,召回率为97.10%,F1分数为95.42%。它分别比ResNet、AlexNet、DenseNet和LSTM高出7.87%、5.65%、3.92%和1.53%,并且分别比ResNet18、CLSTM、VGG19和CNN进一步提高了25.69%、5.29%、2.03%和1.71%的准确率。

讨论

时空特征提取、混合分类和深度分割的集成使得RESIGN在检测AD方面高度可靠。五折交叉验证证明了其稳健性,并且其性能在ADNI数据集上超过了现有模型。然而,由于数据集偏差以及成像条件统一导致的泛化性有限,存在潜在的局限性。

结论

所提出的RESIGN模型通过强大的特征提取和分类,在早期AD检测方面取得了显著改进,为临床诊断提供了可靠的工具。

相似文献

1
RESIGN: Alzheimer's Disease Detection Using Hybrid Deep Learning based Res-Inception Seg Network.RESIGN:基于混合深度学习的Res-Inception分割网络用于阿尔茨海默病检测
Curr Alzheimer Res. 2025 Jun 18. doi: 10.2174/0115672050373821250612053943.
2
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.深度学习方法在自身免疫性大疱性疾病中的直接免疫荧光模式识别。
Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142.
3
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
4
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
5
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
6
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
9
Physostigmine for Alzheimer's disease.用于治疗阿尔茨海默病的毒扁豆碱。
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
10
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.